Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 4 Treatment outcomes of patients with liver abscesses, January 2012 through December 2018, Al Ain, United Arab Emirates

From: Importation of Entamoeba histolytica and predominance of Klebsiella pneumoniae in liver abscesses: a 7-year retrospective cohort study from the United Arab Emirates

Characteristic

All [n 45]

Amoebic liver abscess [n 8]

Pyogenic liver abscess [n 37]

Intervention in addition to antimicrobial therapy n (%)

 Image-guided percutaneous drainage

44 (97.8)

7 (87.5)

37 (100)

 Surgical fenestration and drainage

1 (2.2)

1 (12.5)

0 (0.0)

 Conservative management

0 (0)

0 (0.0)

0 (0.0)

Clinical outcome n (%)

 Critical care admission

8 (17.8)

1 (12.5)

7 (18.9)

 Live discharge

42 (93.3)

7 (87.5)

35 (94.6)

 Died within 30 days of admission

0 (0)

0 (0)

0 (0)

 Left against medical advice

3 (6.7)

1 (12.5)

2 (5.4)

Length of hospital stay [days, median (interquartile range)]

12 (7–16)

7.5 (7–8.5)

14 (9–17)